Huahai Pharmaceutical declines convertible bond price adjustment

Zhejiang Huahai Pharmaceutical announced its board resolved not to adjust the conversion price of its convertible bond downward, despite the company's share price falling below 80% of the current conversion price for at least fifteen trading days within a thirty-day period.

The board stated it would not propose a downward adjustment within the next two months. The conversion price was last adjusted to 33.06 yuan per share on July 10, 2025, down from the initial 34.66 yuan per share.